
Vogel M.E., Idelman G., Konaniah E.S., Zucker S.D. (2017) Bilirubin prevents atherosclerotic lesion formation in low‐density lipoprotein receptor‐deficient mice by inhibiting endothelial VCAM‐1 and ICAM‐1 signaling. JAHA, 1 Apr.
Синдром Жильбера как модель изучения эффектов билирубина